Clinical Genetics · Palo Alto, CA
NPI
1497045298
Since 2011
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
725 Welch Rd
Palo Alto, CA, 94304
Phone (650) 497-8000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.0M
27 prescriptions
Company payments, 2025
$117
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Chung U Lee prescribed most often to Medicare patients was Ravicti (Glycerol Phenylbutyrate), with 21 prescriptions and refills. In total Chung U Lee wrote 27 Medicare prescriptions that cost $2.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ravicti Glycerol Phenylbutyrate | 21 | 21 | Under 11 | $2.0M |
Brand drugs: 22 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chung U Lee $117 ($117 in general payments such as food, travel and fees) from 1 company. The largest payer was Orchard Therapeutics North America with $117.
| Company | Payments | Amount |
|---|---|---|
| Orchard Therapeutics North America | 1 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.